藥品參考
Efbemalenograstim alfa
Efbemalenograstim alfa is a medicine in the class miscellaneous. It is used for febrile neutropenia.
- 藥物類別: Miscellaneous
- 用途: febrile neutropenia
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Miscellaneous
- ATC 代碼
- L03AA18
- 常見劑型
- 注射劑
- 常見規格
- 20 mg/ml
- 商品名
- 2
- 國家與市場
- 2
用途
作用方式
Colony-stimulating factor that binds to specific cell surface receptors on hematopoietic cells, stimulating proliferation, differentiation, commitment, and end cell functional activation.
成人常用劑量（仿單摘要）
Decrease incidence of febrile neutropenia infection in non-myeloid malignancies: 20 mg subcutaneously once per chemotherapy cycle, at least 24 hours after cytotoxic chemotherapy; do not give within 14 days before or <24 hours after chemotherapy
懷孕與哺乳
- 懷孕
- Unknown Data in pregnant women are insufficient to establish a drug-associated risk. Animal studies in rats and rabbits showed no reproductive/developmental toxicity.
- 哺乳
- Unknown No data on presence in milk, effects on the breastfed child, or milk production; weigh breastfeeding benefits against maternal need.
已通報的副作用
- Nausea
- Anemia
- Thrombocytopenia
- Fatigue
- Bone pain
禁忌症
- History of serious allergic reactions to granulocyte stimulating factors such as efbemalenograstim alfa-vuxw, pegfilgrastim, or filgrastim products.
哪些人需要特別留意
- Splenic rupture, including fatal cases: evaluate patients with left upper abdominal or shoulder pain.
- ARDS: evaluate patients with fever, lung infiltrates or respiratory distress; discontinue if ARDS occurs.
- Serious allergic reactions including anaphylaxis: permanently discontinue.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
同類別的其他藥品
常見問題
What is Efbemalenograstim alfa used for?
Efbemalenograstim alfa is a medicine in the class miscellaneous. It is used for Febrile neutropenia.
What side effects have been reported with Efbemalenograstim alfa?
Nausea, Anemia, Thrombocytopenia, Fatigue, Bone pain.
Can Efbemalenograstim alfa be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Data in pregnant women are insufficient to establish a drug-associated risk. Animal studies in rats and rabbits showed no reproductive/developmental toxicity. Breastfeeding: Unknown. No data on presence in milk, effects on the breastfed child, or milk production; weigh breastfeeding benefits against maternal need.
What does Efbemalenograstim alfa interact with?
MediHelp does not list a checked interaction for Efbemalenograstim alfa yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
